Cargando…

The efficacy and safety of the short‐term combination therapy with ticagrelor and PPIs or H2RA in patients with acute STEMI who underwent emergency PCI

Combination therapy with platelet inhibitors and acid‐suppressive agents is recommended for patients with acute ST‐segment elevation myocardial infarction (STEMI) who underwent percutaneous coronary intervention (PCI), but there remains a paucity of data to evaluate both the efficacy and safety of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Peng, Zhuo, Shujiang, Fu, Qiang, Wang, Haibo, Zong, Bin, Cao, Bangming, Wang, Liansheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841456/ https://www.ncbi.nlm.nih.gov/pubmed/34670024 http://dx.doi.org/10.1111/cts.13165

Ejemplares similares

Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
por: Wang, Zhe, et al.
Publicado: (2020)

Effect of ticagrelor on the serum level of hs-CRP, ESM-1 and short-term prognosis of patients with acute STEMI
por: Wei, Peng, et al.
Publicado: (2017)

Remote Ischemic Postconditioning (RIPC) of the Upper Arm Results in Protection from Cardiac Ischemia-Reperfusion Injury Following Primary Percutaneous Coronary Intervention (PCI) for Acute ST-Segment Elevation Myocardial Infarction (STEMI)
por: Cao, Bangming, et al.
Publicado: (2018)

Prevalence and Safety of Prescribing PPIs with Clopidogrel in Palestine
por: Abukhalil, Abdallah Damin, et al.
Publicado: (2023)

New guidelines on primary PCI for patients with STEMI: changing insights
por: van der Wall, E.E.
Publicado: (2015)

Will intravenous paracetamol crush fentanyl in patients undergoing PCI for STEMI?
por: ten Berg, J. M., et al.
Publicado: (2019)

Effect of prehospital treatment in STEMI patients undergoing primary PCI
por: Fabris, Enrico, et al.
Publicado: (2022)

Safety of Bivalirudin Combined with Ticagrelor in the Emergency PCI in Patients with Acute ST-Segment Elevation Myocardial Infarction
por: Wang, Zheng-Dong, et al.
Publicado: (2022)

Short-term efficacy of ticagrelor in acute ST-segment elevation myocardial infarction patients undergoing an emergency percutaneous coronary intervention
por: Cao, Bangming, et al.
Publicado: (2019)

Predictive Value of Gensini Score in the Long-Term Outcomes of Patients With Coronary Artery Disease Who Underwent PCI
por: Wang, Kai-Yang, et al.
Publicado: (2022)

How should the ticagrelor be used? The point after the TWILIGHT and THEMIS-PCI studies
por: Gatto, Laura, et al.
Publicado: (2020)

Assessment of myocardial salvage in patients with STEMI undergoing thrombolysis: ticagrelor versus clopidogrel
por: Petousis, Stylianos, et al.
Publicado: (2022)

Impact of PPIs on patient focused symptomatology in GERD
por: Thomson, ABR
Publicado: (2008)

PPIs and gastric cancer: any causal relationship?
por: Crafa, Pellegrino, et al.
Publicado: (2023)

The Relationship Between the Level of Serum ESM‐1 and Lp‐PLA2 in Patients With Acute ST‐Segment Elevation Myocardial Infarction
por: Wei, Peng, et al.
Publicado: (2020)

Role of tirofiban with dual antiplatelet therapy in patients with STEMI undergoing primary PCI
por: Türker, Yasin
Publicado: (2016)

Impact of periprocedural morphine use on mortality in STEMI patients treated with primary PCI
por: Domokos, Dominika, et al.
Publicado: (2021)

Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach
por: Fabris, Enrico, et al.
Publicado: (2022)

BMI Modifies Increased Mortality Risk of Post-PCI STEMI Patients with AKI
por: Schvartz, Reut, et al.
Publicado: (2022)

LEFT LATERAL VIEW FOR PCI TREATMENT OF INFERIOR STEMI IN A PATIENT WITH DEXTROCARDIA
por: Katić, Josip, et al.
Publicado: (2022)

Complete revascularization with PCI in STEMI patients with multivessel disease, when is the appropriate time?
por: Aquino-Bruno, Heberto, et al.
Publicado: (2023)

Preventive PCI versus culprit lesion stenting during primary PCI in acute STEMI: a systematic review and meta-analysis
por: Pandit, Anil, et al.
Publicado: (2014)

Therapeutic Efficacy of Kangfuxin Liquid Combined with PPIs in Gastric Ulcer
por: Zou, Jun-Bo, et al.
Publicado: (2019)

Rebamipide with Proton Pump Inhibitors (PPIs) versus PPIs Alone for the Treatment of Endoscopic Submucosal Dissection-Induced Ulcers: A Meta-analysis
por: Liu, Junyuan, et al.
Publicado: (2020)

Ticagrelor versus Clopidogrel in Patients with Severe Renal Insufficiency Undergoing PCI for Acute Coronary Syndrome
por: Chen, Yunxian, et al.
Publicado: (2022)

Current status of acid pump antagonists (reversible PPIs).
por: Wurst, W., et al.
Publicado: (1996)

A prospective, observational, multicentre study comparing tenecteplase facilitated PCI versus primary PCI in Indian patients with STEMI (STEPP—AMI)
por: Victor, Suma M, et al.
Publicado: (2014)

Infarct burden following multivessel PCI vs. infarct-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study
por: Mangion, Kenneth, et al.
Publicado: (2015)

The effects of tirofiban infusion on clinical and angiographic outcomes of patients with STEMI undergoing primary PCI
por: Kaymaz, Cihangir, et al.
Publicado: (2016)

Rescue PCI in the management of STEMI: Contemporary results from the Melbourne Interventional Group registry()
por: Fernando, Himawan, et al.
Publicado: (2021)

Prognostic implications and outcomes of cardiac arrest among contemporary patients with STEMI treated with PCI
por: Kumar, Anirudh, et al.
Publicado: (2021)

Impact of COVID-19 pandemic on STEMI undergoing primary PCI treatment in Beijing, China
por: Gong, Xuhe, et al.
Publicado: (2022)

Unrecognized perforation into the anterior interventricular vein complicating PCI for anterior STEMI: An unexpected detour
por: Rothstein, Eric S., et al.
Publicado: (2021)

Primary PCI: a reasonable treatment for STEMI care during the COVID-19 pandemic
por: Jimenez Melo, O, et al.
Publicado: (2021)

The abnormal level and prognostic potency of multiple inflammatory cytokines in PCI‐treated STEMI patients
por: Zhang, Jing, et al.
Publicado: (2022)

Heart Block Caused by Ticagrelor Use in a Patient Who Underwent Adenosine Diastolic Fractional Reserve Assessment: A Case Report
por: Al-Bayati, Asseel, et al.
Publicado: (2021)

Ticagrelor vs. clopidogrel for coronary microvascular dysfunction in patients with STEMI: a meta-analysis of randomized controlled trials
por: Li, Yike, et al.
Publicado: (2023)

The predictive value of eosinophil levels on no-reflow in patients with STEMI following PCI: a retrospective cohort study
por: Mo, De-Gang, et al.
Publicado: (2022)

Plasma DPP4 activity is associated with no-reflow and major bleeding events in Chinese PCI-treated STEMI patients
por: Li, Jing Wei, et al.
Publicado: (2016)

24-h PCI model does affect the outcome of STEMI patients: a population-based study
por: Tsai, Chang-Hung, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6lvkiv5kgvhamojq8d53htns8o